Massive decline in technology stocks following earnings releases from Apple and Microsoft dragged major benchmarks to negative territory for the second-consecutive day. Meanwhile, another slump in oil prices also weighed on energy shares, which in turn had a negative impact on markets. However, encouraging existing home sales data boosted housing stocks on Wednesday.For a look at the issues currently facing […]
One of the most popular and well-known names in the biotech world is definitely Biogen (BIIB-Analyst Report). This large cap stock has been a staple of investor portfolios in the biotechnology space for some time, while it is also one of the behemoths of the sector, closing in on $100 billion in market cap.BIIB might be due for a breather […]
The Celgene Corporation (CELG – Analyst Report) – Juno Therapeutics’ (JUNO – Analyst Report) immunotherapy deal worth at least a billion dollars was the main story in the biotech sector this week. While concerns are being raised about the high price tag, the deal just goes to show the growing interest in the field of immunotherapy. Meanwhile, quite a few […]
Setback in bailout talks between Greece and its creditors over the weekend continued to negatively impact benchmarks on Tuesday. The lack of progress in Greek debt talks raised fears among investors of a possible default by Greece and the country’s exit from the Eurozone. Meanwhile, manufacturing activity worsened slightly for New York manufacturers and decline in U.S. industrial production in […]
An FDA advisory panel voted in favor of approving Regeneron (REGN – Analyst Report) and partner Sanofi’s PCSK9 inhibitor, Praluent. A few deals were also signed over the last few days by companies like Vertex (VRTX – Analyst Report), Celgene (CELG – Analyst Report) and Seattle Genetics (SGEN – Analyst Report).Recap of the Week’s Most Important Stories1. Regeneron and Sanofi […]
Benchmarks ended the first trading day of the week in the red, dragged down by declines in technology stocks. Drop in airline stocks also weighed on the broader markets. The lack of progress related to Greece’s debt deal with its creditors also dented investor sentiment. Meanwhile, Friday’s upbeat jobs data continued to intensify concerns about rate hike as early as […]
Benchmarks ended in the red on Thursday as a decline in jobless claims raised concerns about rate hike sooner than later. Meanwhile, IMF urged Fed not to hike rates until next year provided there is a clear indication of a pick up in wages and inflation rate. IMF also trimmed growth forecast on U.S economy, which added to investor concern. […]
Benchmarks ended with modest gains on Wednesday, banking on positive economic reports and hopes of an imminent deal between Greece and its creditors. While private sector hiring picked up in May, trade deficit narrowed last month. European Central Bank’s commitment toward its bond buying program also lifted investor sentiment.For a look at the issues currently facing the markets, make sure […]
Benchmarks ended the first trading day of June with modest gains following mixed economic reports. While reports on construction spending and manufacturing were encouraging, data on consumer spending was disappointing. Investors are keeping an eye on economic data for clues on when the Federal Reserve will hike interest rates.For a look at the issues currently facing the markets, make sure […]
Benchmarks ended about 1% lower on Tuesday following a rise in the dollar and upbeat economic data. While an increase in the dollar compelled investors to reduce their exposure on riskier assets including equities, encouraging economic data raised anxiety of a rate hike sooner than later. Meanwhile, concerns about Greek’s debt crisis added to the bearish sentiment. The S&P 500 […]
